Skip to main content
Journal of Ophthalmic Inflammation and Infection
Fig. 2 | Journal of Ophthalmic Inflammation and Infection

Fig. 2

From: Peripheral ulcerative keratitis associated with tralokinumab therapy: a case report and review of IL-13 inhibitor-associated ocular surface disease

Fig. 2

Though improving at the time of photography after three days of oral prednisone therapy, a crescentic corneal infiltrate remains present near the inferior limbus. Significant leukocytic stromal inflammation remains, with reactive corneal neovascularization, a breakdown of corneal epithelium overlying the infiltrate, and loss of 20% stromal thickness

Back to article page